These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6829493)

  • 21. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
    Abele R; Alberto P; Kaplan S; Siegenthaler P; Hofmann V; Ryssel HJ; Hartmann D; Holdener EE; Cavalli F
    J Clin Oncol; 1983 Dec; 1(12):750-4. PubMed ID: 6230419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CBDCA: phase II evaluation in advanced colorectal carcinoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Apr; 10(2):136-8. PubMed ID: 3551576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.
    Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(3):577-9. PubMed ID: 1203884
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase I study of L-alanosine using a daily x 3 schedule.
    Dosik GM; Stewart D; Valdivieso M; Burgess MA; Bodey GP
    Cancer Treat Rep; 1982 Jan; 66(1):73-6. PubMed ID: 7053269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
    Holdener EE; Hansen HH; Høst H; Bruntsch U; Cavalli F; Renard J; Pinedo HM; Rozencweig M
    Invest New Drugs; 1985; 3(1):63-6. PubMed ID: 3857219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of iproplatin (CHIP) in previously untreated patients with colorectal cancer.
    Blitzer JB; Newman N; Ginsberg SJ; Louie A; Scalzo A; Poiesz B
    Am J Clin Oncol; 1988 Dec; 11(6):650-1. PubMed ID: 3189231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCNU: phase II evaluation in advanced colorectal carcinoma.
    Pazdur R; Samson MK; Baker LH
    Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of bisantrene in advanced colorectal carcinoma.
    Ahmed T; Kemeny NE; Michaelson RA; Harper HD
    Cancer Treat Rep; 1983 Mar; 67(3):307-8. PubMed ID: 6831479
    [No Abstract]   [Full Text] [Related]  

  • 29. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
    Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
    Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
    J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of daunorubicin in previously untreated patients with advanced colorectal carcinoma.
    Harvey J; Bonnem E; Grady K; Goodman A; Schein P
    Med Pediatr Oncol; 1985; 13(1):30-1. PubMed ID: 3969059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
    Michaelson R; Kemeny N; Young C
    Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of 10-deaza-aminopterin in patients with advanced colorectal cancer.
    Cheng EW; Currie VE; Yagoda A
    Am J Clin Oncol; 1983 Aug; 6(4):469-71. PubMed ID: 6869317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of spirogermanium in patients with advanced colorectal carcinoma.
    Ajani JA; Faintuch JS; McClure RK; Levin B; Boman BM; Krakoff IH
    Invest New Drugs; 1986; 4(4):383-5. PubMed ID: 3583645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
    O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
    Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
    Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II evaluation of anguidine (NSC-141537) for adenocarcinoma of the colon or rectum.
    Diggs CH; Scoltock MJ; Wiernik PH
    Cancer Clin Trials; 1978; 1(4):297-9. PubMed ID: 757146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.